Find Research Outputs

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017

Author

  • Toshihiro Miyamoto
2019

Prophylactic antiemetics for haematological malignancies: Prospective nationwide survey subset analysis in Japan

Yoshida, I., Tamura, K., Miyamoto, T., Shimokawa, M., Takamatsu, Y., Nanya, Y., Matsumura, I., Gotoh, M., Igarashi, T., Takahashi, T., Aiba, K., Kumagai, K., Ishizawa, K., Kurita, N., Usui, N. & Hatake, K., Jan 1 2019, In : In Vivo. 33, 4, p. 1355-1362 8 p.

Research output: Contribution to journalArticle

Open Access
2017

Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs

Tochigi, T., Aoki, T., Kikushige, Y., Kamimura, T., Ito, Y., Shima, T., Yamauchi, T., Mori, Y., Yoshimoto, G., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Akashi, K. & Miyamoto, T., Apr 1 2017, In : International journal of hematology. 105, 4, p. 423-432 10 p.

Research output: Contribution to journalArticle

2019

Prospective evaluation of minimal residual disease monitoring to predict prognosis of adult patients with Ph-negative acute lymphoblastic leukemia

Nagafuji, K., Miyamoto, T., Eto, T., Ogawa, R., Okumura, H., Takase, K., Kawano, N., Miyazaki, Y., Fujisaki, T., Wake, A., Ohno, Y., Kurokawa, T., Kamimura, T., Takamatsu, Y., Yokota, S. & Akashi, K., Jan 1 2019, In : European Journal of Haematology. 103, 3, p. 164-171 8 p.

Research output: Contribution to journalArticle

2020
Open Access
2019

Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

For the Fukuoka Blood and Marrow Transplantation Group, Jan 22 2019, In : International journal of hematology. 109, 1, p. 98-106 9 p.

Research output: Contribution to journalArticle

2017
2020

Phase I/II study of bortezomib, lenalidomide, and dexamethasone treatment for relapsed and refractory multiple myeloma

Fukuoka Blood and Marrow Transplantation Group, May 1 2020, In : International journal of hematology. 111, 5, p. 673-680 8 p.

Research output: Contribution to journalArticle

Outcome of allogeneic hematopoietic stem cell transplantation for mycosis fungoides and Sézary syndrome

Mori, T., Shiratori, S., Suzumiya, J., Kurokawa, M., Shindo, M., Naoyuki, U., Katsuto, T., Miyamoto, T., Morishige, S., Hirokawa, M., Fukuda, T., Atsuta, Y. & Suzuki, R., Jan 1 2020, (Accepted/In press) In : Hematological Oncology.

Research output: Contribution to journalArticle

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors: Allo-HCT for ATL from HTLV-1 Antibody-Positive Donors

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, Apr 2020, In : Biology of Blood and Marrow Transplantation. 26, 4, p. 718-722 5 p.

Research output: Contribution to journalArticle

2017

Comparison between antiemetic effects of palonosetron and granisetron on chemotherapy-induced nausea and vomiting in Japanese patients treated with R-CHOP

Uchida, M., Mori, Y., Nakamura, T., Kato, K., Kamezaki, K., Takenaka, K., Shiratsuchi, M., Kadoyama, K., Miyamoto, T. & Akashi, K., Jan 1 2017, In : Biological and Pharmaceutical Bulletin. 40, 9, p. 1499-1505 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2018

Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation

ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation, Apr 2018, In : Biology of Blood and Marrow Transplantation. 24, 4, p. 832-839 8 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2017

Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation

Suetsugu, K., Ikesue, H., Miyamoto, T., Shiratsuchi, M., Yamamoto-Taguchi, N., Tsuchiya, Y., Matsukawa, K., Uchida, M., Watanabe, H., Akashi, K. & Masuda, S., Mar 1 2017, In : International journal of hematology. 105, 3, p. 361-368 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2018

Comparison of antiemetic effects of granisetron and palonosetron in patients receiving bendamustine-based chemotherapy

Uchida, M., Nakamura, T., Makihara, Y., Suetsugu, K., Ikesue, H., Mori, Y., Kato, K., Shiratsuchi, M., Hosohata, K., Miyamoto, T. & Akashi, K., Jan 1 2018, In : Pharmazie. 73, 5, p. 304-308 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2019

Previous exposure to bortezomib is linked to a lower risk of engraftment syndrome after autologous hematopoietic stem cell transplantation

Mori, Y., Yoshimoto, G., Yuda, J. I., Hayashi, M., Odawara, J., Kuriyama, T., Sugio, T., Miyawaki, K., Kamezaki, K., Kato, K., Takenaka, K., Iwasaki, H., Maeda, T., Miyamoto, T. & Akashi, K., Jan 2 2019, In : Leukemia and Lymphoma. 60, 1, p. 271-273 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT), Jan 22 2019, In : International journal of hematology. 109, 1, p. 107-114 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma

Yamasaki, S., Chihara, D., Kim, S. W., Kawata, T., Mizuta, S., Ago, H., Chou, T., Yamane, T., Uchiyama, H., Oyake, T., Miura, K., Saito, B., Taji, H., Nakamae, H., Miyamoto, T., Fukuda, T., Kanda, J., Atsuta, Y. & Suzuki, R., Feb 20 2019, In : International journal of hematology. 109, 2, p. 175-186 12 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
2018

Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open-label phase 1 study

Usuki, K., Sakura, T., Kobayashi, Y., Miyamoto, T., Iida, H., Morita, S., Bahceci, E., Kaneko, M., Kusano, M., Yamada, S., Takeshita, S., Miyawaki, S. & Naoe, T., Oct 2018, In : Cancer Science. 109, 10, p. 3235-3244 10 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)
2019
5 Citations (Scopus)

Anti-GPRC5D/CD3 bispecific T-cell-redirecting antibody for the treatment of multiple myeloma

Kodama, T., Kochi, Y., Nakai, W., Mizuno, H., Baba, T., Habu, K., Sawada, N., Tsunoda, H., Shima, T., Miyawaki, K., Kikushige, Y., Mori, Y., Miyamoto, T., Maeda, T. & Akashi, K., Jan 1 2019, In : Molecular Cancer Therapeutics. 18, 9, p. 1555-1564 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
Open Access
2020

Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab

Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation, Apr 1 2020, In : Hematological Oncology. 38, 2, p. 146-152 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)